More and more Spaniards are taking drugs to lower their DHT

The use of drugs to reduce dihydrotestosterone is growing in Spain. Effective treatment or overmedication? The data is divided.

English · Original discussion in Spanish · Published

DHT lowered with drugs: why are so many Spaniards medicating themselves?

More and more Spaniards are taking medication to reduce their dihydrotestosterone, the hormone that accelerates hair loss and enlarges the prostate. The promise is simple: keep your temples intact and avoid the operating room. The reality, as is often the case with hormonal treatments, is not so straightforward.

DHT is the active form of testosterone. Blocking its production with 5-alpha-reductase inhibitor drugs has become a habit for many men. But skepticism is not lacking. Some point out that hair falls out anyway, that results take months, and that paying for a head of hair that refuses to cooperate can end in frustration.

Beyond aesthetics, the issue touches a social nerve: the feeling that the population is overmedicated. The same concern that applies to anti-anxiety drugs — with lorazepam as a recurring example — is now being extended to antiandrogens. Between the pharmacy and prevention, the average Spaniard has become their own laboratory. The long-term side effects, which include sensual and mood alterations, are mentioned in the package inserts, but rarely in everyday conversation.

With the ball in the court of scientific evidence, the decision remains an individual one. Let everyone decide, that is, with data on the table and not with slogans. Because if this issue teaches us anything, it is that playing with your own hormones is an experiment with unpredictable results: the body responds as it wants, not as the package insert promises.

Also available in: Deutsch

Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (14 replies).

More summaries

All summaries in English →

-
Back